Virpax Pharmaceuticals, Inc. (VRPX) earnings
VRPX earnings moved a median of -5.01% by the close. Quarterly and annual VRPX reports and results, each read against the price at its own news timestamp. Back to the VRPX overview →
12 measured VRPX earnings events.
Where these VRPX earnings landedvs 12 measured VRPX earnings reactions
| Middle 50% of VRPX earnings reactions | -7.72% to +0.78% |
|---|---|
| Median reaction (to close) | -5.01% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 VRPX earnings events with a measured close landed between -7.72% and +0.78%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K Virpax Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.16% | +0.00% | |
| Form 10-Q Virpax Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +5.26% | -6.94% | |
| Form 10-K/A Virpax Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.09% | |
| Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments | Press release | +7.60% | -7.72% | |
| Form 10-Q Virpax Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +7.60% | -7.72% | |
| Form 10-Q Virpax Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | — | -22.37% | |
| Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments | Press release | — | -22.37% | |
| Form 10-K Virpax Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +2.65% | |
| Form 10-Q Virpax Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -8.78% | +6.76% | |
| Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing | Press release | +0.00% | +0.16% | |
| Form NT 10-Q Virpax Pharmaceuticals, For: Sep 30 | SEC filing · Form NT | — | -7.24% | |
| Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments | Press release | +0.00% | +5.93% |
Keep exploring
More VRPX: analyst actions → · SEC filings → · VRPX overview →